-
February 19, 2019PREVIEW
Patients with hypertriglyceridemia on statin therapy who received icosapent ethyl (Vascepa—Amarin) had a significant reduction in adverse cardiovascular (CV) events compared with patients...
-
January 7, 2019PREVIEW
Adding alirocumab (Praluent—Sanofi, Regeneron) to high-intensity statin therapy for patients who had an acute coronary syndrome (ACS) in the preceding 12 months resulted in a significantly lower...
-
December 26, 2018PREVIEW
The American College of Cardiology (ACC) and American Heart Association (AHA) task force released an updated guideline on management of high cholesterol. The guideline has a greater focus on...
-
November 20, 2018PREVIEW
In people older than age 74 years without diabetes, statin use for primary prevention was not associated with a reduction in the risk of atherosclerotic cardiovascular (CV) disease or all-cause...
-
September 25, 2018PREVIEW
Patients who used statins after a stroke had a reduced risk of osteoporosis, hip fracture, and vertebral fracture compared with those who did not use statins, with a dose-effect relationship...
Pages
